Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Angina

Ivabradine for treatment of stable angina pectoris

Nature Reviews Cardiology volume 6, pages 329–330 (2009)Cite this article

The ASSOCIATE study investigators have reported that the If current inhibitor, ivabradine, is safe, improves exercise performance, and delays the development of ischemia in patients with chronic stable angina being treated with atenolol. Ivabradine should be considered in the medical management of symptom-limited patients with angina, when heart rate is suboptimally controlled.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Fox, K. et al. Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology. Eur. Heart J. 27, 1341–1381 (2006).

    Article  Google Scholar 

  2. Kannel, W. B. & Feinleib, M. Natural history of angina pectoris in the Framingham study. Prognosis and survival. Am. J. Cardiol. 29, 154–163 (1972).

    Article  CAS  Google Scholar 

  3. Gibbons, R. J. et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina—summary article: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on the Management of Patients With Chronic Stable Angina). J. Am. Coll. Cardiol. 41, 159–168 (2003).

    Article  Google Scholar 

  4. Tardif, J. C., Ponikowski, P. & Kahan, T. Efficacy of the If current inhibitor ivabradine in patients with chronic stable angina receiving beta-blocker therapy: a 4-month, randomized, placebo-controlled trial. Eur. Heart J. 30, 540–548 (2009).

    Article  CAS  Google Scholar 

  5. Fox, K. M. Exercise heart rate/ST segment relation. Perfect predictor of coronary disease. Br. Heart J. 48, 309–310 (1982).

    Article  CAS  Google Scholar 

  6. Gislason, G. H. et al. Long-term compliance with beta-blockers, angiotensin-converting enzyme inhibitors, and statins after acute myocardial infarction. Eur. Heart J. 27, 1153–1158 (2006).

    Article  CAS  Google Scholar 

  7. Fox, K. M., Mulcahy, D., Findlay, I., Ford, I. & Dargie, H. J. The Total Ischaemic Burden European Trial (TIBET). Effects of atenolol, nifedipine SR and their combination on the exercise test and the total ischaemic burden in 608 patients with stable angina. The TIBET Study Group. Eur. Heart J. 17, 96–103 (1996).

    Article  CAS  Google Scholar 

  8. Klein, W. W., Jackson, G. & Tavazzi, L. Efficacy of monotherapy compared with combined antianginal drugs in the treatment of chronic stable angina pectoris: a meta-analysis. Coron. Artery Dis. 13, 427–436 (2002).

    Article  Google Scholar 

  9. Knight, C. J. & Fox, K. M. Amlodipine versus diltiazem as additional antianginal treatment to atenolol. Centralised European Studies in Angina Research (CESAR) Investigators. Am. J. Cardiol. 81, 133–136 (1998).

    Article  CAS  Google Scholar 

  10. Borer, J. S., Fox, K., Jaillon, P. & Lerebours, G. Antianginal and antiischemic effects of ivabradine, an If inhibitor, in stable angina: a randomized, double-blind, multicentered, placebo-controlled trial. Circulation 107, 817–823 (2003).

    Article  Google Scholar 

  11. Tardif, J. C., Ford, I., Tendera, M., Bourassa, M. G. & Fox, K. Efficacy of ivabradine, a new selective If inhibitor, compared with atenolol in patients with chronic stable angina. Eur. Heart J. 26, 2529–2536 (2005).

    Article  CAS  Google Scholar 

  12. Boden, W. E. et al. Optimal medical therapy with or without PCI for stable coronary disease. N. Engl. J. Med. 356, 1503–1516 (2007).

    Article  CAS  Google Scholar 

  13. Daly, C. A. et al. The initial management of stable angina in Europe, from the Euro Heart Survey: a description of pharmacological management and revascularization strategies initiated within the first month of presentation to a cardiologist in the Euro Heart Survey of Stable Angina. Eur. Heart J. 26, 1011–1022 (2005).

    Article  Google Scholar 

  14. Chaitman, B. R. et al. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial. JAMA 291, 309–316 (2004).

    Article  CAS  Google Scholar 

  15. Fox, K., Ford, I., Steg, P. G., Tendera, M. & Ferrari, R. Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial. Lancet 372, 807–816 (2008).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cardiology, Royal Brompton and Harefield NHS Trust, National Heart and Lung Institute, Imperial College London, London, UK

    Ranil de Silva & Kim M. Fox

Authors
  1. Ranil de Silva
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kim M. Fox
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kim M. Fox.

Ethics declarations

Competing interests

R. de Silva has received speakers' bureau honoraria from Servier. K. M. Fox has acted as a Consultant for and has received speakers' bureau honoraria and research support from Servier.

Rights and permissions

Reprints and permissions

About this article

Cite this article

de Silva, R., Fox, K. Ivabradine for treatment of stable angina pectoris. Nat Rev Cardiol 6, 329–330 (2009). https://doi.org/10.1038/nrcardio.2009.47

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrcardio.2009.47

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing